Company Description
Brookfield Corporation (OTC Link: BAMKF) is a publicly traded asset management company in the Financial Services sector.
BAMKF stock has gained 10.3% over the past year.
On a trailing twelve-month basis, Brookfield Corporation reported revenue of $75.1B with net income of $3.2B. The company operates at a net profit margin of 4.3%.
This page provides a comprehensive overview of BAMKF stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Brookfield Corporation (BAMKF) stock. Over the past 12 months, the stock has gained 10.3%.
BAMKF Rankings
Latest News
SEC Filings
Brookfield Corporation has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form 3. The most recent filing was submitted on July 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BAMKF SEC filings →
Financial Highlights
Brookfield Corporation generated $75.1B in revenue over the trailing twelve months, and net income was $3.2B, reflecting a 4.3% net profit margin. The company generated $11.0B in operating cash flow.
Upcoming Events
Short Interest History
Short interest in Brookfield Corporation (BAMKF) currently stands at 81 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Brookfield Corporation (BAMKF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
BAMKF Company Profile & Sector Positioning
Brookfield Corporation (BAMKF) operates in the Asset Management industry within the broader Financial Services sector and is listed on the OTC Link.